(TheNewswire)

Vancouver, British Columbia – May 8, 2025 – TheNewswire - Orion Nutraceuticals Inc. , (CSE: ORI ) (the “ Company ” or “ Orion ”) announces the appointment of Troy Grant as a Director of the Company.

Mr. Grant brings a wealth of experience in corporate leadership, capital markets, and strategic growth across a range of industries. His appointment supports Orion’s ongoing commitment to strengthening its governance and advancing its strategic objectives.

The Company welcomes Mr. Grant to the Board and looks forward to benefiting from his insight and contributions.

About Orion Nutraceuticals Inc.

Orion Nutraceuticals Inc. is actively evaluating potential investment and acquisition opportunities. Orion shares trade in Canada on the CSE under the symbol ORI.

ON BEHALF OF THE BOARD

Guy Bourgeois, CEO
Tel: ( 604) 687-2038

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedarplus.ca.

Copyright (c) 2025 TheNewswire - All rights reserved.